Profile data is unavailable for this security.
About the company
Promimic AB is a Sweden-based biomaterial company. The Company manufactures, markets and sells biomaterials for improved osseointegration (bone healing) to the companies in the markets for orthopedic and dental implants. The Company operates primarily in the United States, Europe, and South America, with current product applications in the dental, spine, total joint, extremities, and sports medicine implant markets.
- Revenue in SEK (TTM)40.92m
- Net income in SEK-10.45m
- Incorporated2004
- Employees17.00
- LocationPromimic ABEntreprenorsstraket 10MOELNDAL 431 53SwedenSWE
- Phone+46 31160860
- Websitehttps://promimic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xbrane Biopharma AB | 199.81m | -304.77m | 310.49m | 65.00 | -- | 1.19 | -- | 1.55 | -0.7304 | -0.9784 | 0.2266 | 0.1701 | 0.2309 | 0.4396 | 5.01 | 2,148,473.00 | -35.22 | -40.98 | -70.65 | -67.24 | 61.87 | -- | -152.53 | -364.40 | 0.8986 | -8.52 | 0.3957 | -- | 314.33 | 63.42 | -91.10 | -- | 60.02 | -- |
| Bergenbio ASA | 519.42k | -151.83m | 312.30m | 15.00 | -- | 2.04 | -- | 601.24 | -4.93 | -4.93 | 0.0162 | 3.92 | 0.0027 | -- | 0.0384 | 20,840.00 | -79.58 | -66.15 | -96.80 | -78.74 | -- | -- | -29,229.94 | -11,419.44 | -- | -- | 0.00 | -- | -9.00 | -31.43 | 36.98 | -- | -- | -- |
| Oncopeptides AB | 27.07m | -282.39m | 314.01m | 79.00 | -- | 2.32 | -- | 11.60 | -1.94 | -1.94 | 0.1763 | 0.6421 | 0.0882 | 0.8441 | 0.6929 | 474,929.80 | -91.96 | -141.28 | -107.34 | -200.49 | 89.97 | -- | -1,043.16 | -2,689.06 | 6.16 | -199.53 | 0.5030 | -- | 321.54 | -- | 26.29 | -- | -- | -- |
| Saniona AB | 24.88m | -81.81m | 315.52m | 22.00 | -- | 45.24 | -- | 12.68 | -0.9821 | -0.9821 | 0.2822 | 0.0623 | 0.2386 | -- | 6.23 | 1,081,652.00 | -78.47 | -59.16 | -168.78 | -70.15 | -92.01 | -970.05 | -328.83 | -1,483.55 | -- | -3.03 | 0.8668 | -- | 10.19 | -21.05 | 54.71 | -- | -34.94 | -- |
| Alzinova AB | 300.00k | -18.72m | 329.91m | 5.00 | -- | 2.53 | -- | 1,099.71 | -0.3144 | -0.3144 | 0.0048 | 1.46 | 0.0023 | -- | 0.4478 | 60,000.00 | -14.06 | -10.77 | -14.94 | -11.27 | -2,642.00 | -- | -6,240.33 | -18,447.90 | -- | -172.34 | 0.0061 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
| Cantargia AB | 0.00 | -193.53m | 335.78m | 21.00 | -- | 6.86 | -- | -- | -1.07 | -1.07 | 0.00 | 0.2664 | 0.00 | -- | -- | 0.00 | -121.74 | -55.08 | -165.80 | -61.35 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 24.69 | -- | -- | -- |
| Initiator Pharma A/S | 0.00 | -26.36m | 362.18m | 3.00 | -- | 13.00 | -- | -- | -0.4803 | -0.4803 | 0.00 | 0.5256 | 0.00 | -- | -- | 0.00 | -65.39 | -68.27 | -73.28 | -74.02 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 27.95 | -- | -- | -- |
| Hamlet BioPharma AB | 0.00 | -41.82m | 362.85m | 7.00 | -- | 7.39 | -- | -- | -0.2756 | -0.2756 | 0.00 | 0.3842 | 0.00 | -- | -- | 0.00 | -86.17 | -80.47 | -92.51 | -97.51 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -104.57 | -- | -- | -- |
| SynAct Pharma AB | 0.00 | -154.57m | 370.02m | 6.00 | -- | 2.19 | -- | -- | -4.25 | -4.25 | 0.00 | 4.10 | 0.00 | -- | -- | 0.00 | -62.70 | -125.17 | -70.31 | -151.70 | -- | -- | -- | -- | -- | -199.31 | 0.0084 | -- | -- | -- | -117.54 | -- | -- | -- |
| Alligator Bioscience AB | 27.73m | -248.31m | 381.29m | 47.00 | -- | -- | -- | 13.75 | -0.3667 | -0.3667 | 0.0403 | -0.1001 | 0.201 | -- | 9.80 | 478,017.30 | -180.01 | -73.26 | -2,941.13 | -91.33 | -- | -- | -895.60 | -811.68 | -- | -27.01 | -- | -- | 62.78 | 16.60 | -28.53 | -- | -20.34 | -- |
| Curasight A/S | -44.31m | -49.50m | 391.54m | 4.00 | -- | 19.81 | -- | -- | -1.51 | -1.51 | -1.35 | 0.6008 | -0.7563 | -- | -- | -7,107,500.00 | -84.49 | -24.61 | -111.31 | -26.01 | -- | -- | -- | -- | -- | -32.26 | 0.4439 | -- | -123.97 | -- | -42.62 | -- | -- | -- |
| Mendus AB (publ) | 0.00 | -138.05m | 465.57m | 28.00 | -- | 0.689 | -- | -- | -3.00 | -3.00 | 0.00 | 13.42 | 0.00 | -- | -- | 0.00 | -18.07 | -18.84 | -18.77 | -20.21 | -- | -- | -- | -28,474.53 | -- | -- | 0.0322 | -- | -100.00 | -- | 26.78 | -- | -- | -- |
| Thor Medical ASA | 0.00 | -18.50m | 552.59m | 1.00 | -- | 2.13 | -- | -- | -0.0873 | 0.021 | 0.00 | 1.11 | 0.00 | -- | -- | 0.00 | -9.82 | -79.17 | -10.54 | -113.94 | -- | -- | -- | -- | -- | -- | 0.0035 | -- | -- | -- | -- | -- | -- | -- |
| Promimic AB | 40.92m | -10.45m | 615.69m | 17.00 | -- | 8.68 | -- | 15.05 | -0.563 | -0.563 | 2.21 | 3.80 | 0.4828 | -3.88 | 3.92 | 2,406,824.00 | -12.33 | -24.89 | -14.16 | -29.25 | 104.60 | 101.23 | -25.54 | -89.47 | 4.51 | -- | 0.00 | -- | 128.63 | -- | 41.95 | -- | -- | -- |
| Arcticzymes Technologies ASA | 107.86m | 6.98m | 671.08m | 68.00 | 96.43 | 2.11 | 51.82 | 6.22 | 0.1367 | 0.1367 | 2.10 | 6.24 | 0.3199 | 0.45 | 1.93 | 1,591,059.00 | 2.07 | 15.58 | 2.19 | 17.22 | 93.99 | 96.69 | 6.47 | 33.23 | 14.95 | -- | 0.0273 | 0.00 | -13.16 | 12.24 | -40.89 | -- | 47.93 | -- |
| Nykode Therapeutics ASA | 67.67m | -417.40m | 901.69m | 179.00 | -- | 0.5386 | -- | 13.32 | -1.34 | -1.34 | 0.2122 | 5.14 | 0.0333 | -- | 1.59 | 392,363.40 | -20.57 | 5.65 | -23.15 | 6.38 | -- | -- | -616.79 | 18.13 | -- | -- | 0.0305 | -- | 79.99 | 282.17 | 17.75 | -- | 187.37 | -- |
Data as of Nov 21 2024. Currency figures normalised to Promimic AB's reporting currency: Swedish Krona SEK
10.70%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Andra AP-fondenas of 31 Dec 2023 | 958.09k | 5.14% |
| Swedbank Robur Fonder ABas of 31 Dec 2023 | 624.00k | 3.35% |
| Protean Funds Scandinavia ABas of 31 Dec 2023 | 310.33k | 1.66% |
| Schroder Investment Management Ltd.as of 31 Dec 2023 | 100.00k | 0.54% |
| FCG Fonder ABas of 31 Oct 2024 | 3.92k | 0.02% |
| Wahlstedt & Partners ABas of 30 Sep 2024 | 0.00 | 0.00% |
More ▼
Data from 15 Feb 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
